Symbols

LFST

LifeStance Health·NASDAQ

--(--)

LFST fundamentals

LFST Q4 2025 Earnings

LifeStance Health (LFST) released its earnings on Feb 25, 2026: revenue was 382.20M (YoY +17.42%), beat estimates; EPS was 0.01 (YoY +200.00%), beat estimates.

Revenue / YoY

382.20M

+17.42%

EPS / YoY

0.01

+200.00%

Report date

Feb 25, 2026

LFST Earnings Call Summary for Q4,2025

【Key Takeaways】

Revenue Growth: 14% YoY in 2025, guided for 14-15% in 2026, driven by clinician adds and productivity gains.
Margin Expansion: Adjusted EBITDA margin of 11.1% in 2025, targeting 11.9% in 2026 with long-term goal of mid-teens by 2028.
Strategic Investments: $100M share buyback program and $20M-$30M EHR implementation to enhance clinician efficiency and patient care.
Specialty Growth: Specialty services (TMS, SPRAVATO) to reach $70M in 2026, 40% YoY growth.
Financial Health: Positive net income in 2025, free cash flow of $110M, and disciplined M&A approach for geographic expansion.

Earnings

EPS

Revenue

Revenue & Expenses

LFST has released its 2025 Q4 earnings report, with revenue of 382.19M, reflecting a YoY change of 17.43%, and net profit of 11.67M, showing a YoY change of 264.06%. The Sankey diagram below clearly presents LFST's revenue sources and cost distribution.

Key Indicators

LifeStance Health (LFST) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

LifeStance Health (LFST)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

LifeStance Health (LFST)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

LifeStance Health (LFST)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown